The Ischemic Stroke Genetics Study (ISGS) Protocol

James F Meschia, Thomas G Brott, Robert D Jr. Brown, Richard J P Crook, Michael Frankel, John Hardy, José G. Merino, Stephen S. Rich, Scott Silliman, Bradford Burke Worrall

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: The molecular basis for the genetic risk of ischemic stroke is likely to be multigenic and influenced by environmental factors. Several small case-control studies have suggested associations between ischemic stroke and polymorphisms of genes that code for coagulation cascade proteins and platelet receptors. Our aim is to investigate potential associations between hemostatic gene polymorphisms and ischemic stroke, with particular emphasis on detailed characterization of the phenotype. Methods/Design: The Ischemic Stroke Genetic Study is a prospective, multicenter genetic association study in adults with recent first-ever ischemic stroke confirmed with computed tomography or magnetic resonance imaging. Patients are evaluated at academic medical centers in the United States and compared with sex- and age-matched controls. Stroke subtypes are determined by central blinded adjudication using standardized, validated mechanistic and syndromic classification systems. The panel of genes to be tested for polymorphisms includes β-fibrinogen and platelet glycoprotein Ia, Iba, and IIb/IIIa. Immortalized cell lines are created to allow for time- and cost-efficient testing of additional candidate genes in the future. Discussion: The study is designed to minimize survival bias and to allow for exploring associations between specific polymorphisms and individual subtypes of ischemic stroke. The data set will also permit the study of genetic determinants of stroke outcome. Having cell lines will permit testing of future candidate risk factor genes.

Original languageEnglish (US)
Article number4
JournalBMC Neurology
Volume3
DOIs
StatePublished - Jul 8 2003

Fingerprint

Stroke
Genes
Integrin alpha2
Cell Line
Genetic Association Studies
Hemostatics
Fibrinogen
Case-Control Studies
Molecular Biology
Blood Platelets
Tomography
Magnetic Resonance Imaging
Phenotype
Costs and Cost Analysis
Survival
Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Neurology

Cite this

The Ischemic Stroke Genetics Study (ISGS) Protocol. / Meschia, James F; Brott, Thomas G; Brown, Robert D Jr.; Crook, Richard J P; Frankel, Michael; Hardy, John; Merino, José G.; Rich, Stephen S.; Silliman, Scott; Burke Worrall, Bradford.

In: BMC Neurology, Vol. 3, 4, 08.07.2003.

Research output: Contribution to journalArticle

Meschia, JF, Brott, TG, Brown, RDJ, Crook, RJP, Frankel, M, Hardy, J, Merino, JG, Rich, SS, Silliman, S & Burke Worrall, B 2003, 'The Ischemic Stroke Genetics Study (ISGS) Protocol', BMC Neurology, vol. 3, 4. https://doi.org/10.1186/1471-2377-3-4
Meschia, James F ; Brott, Thomas G ; Brown, Robert D Jr. ; Crook, Richard J P ; Frankel, Michael ; Hardy, John ; Merino, José G. ; Rich, Stephen S. ; Silliman, Scott ; Burke Worrall, Bradford. / The Ischemic Stroke Genetics Study (ISGS) Protocol. In: BMC Neurology. 2003 ; Vol. 3.
@article{ffdee7b6f6a24877bd4a95edfff52da4,
title = "The Ischemic Stroke Genetics Study (ISGS) Protocol",
abstract = "Background: The molecular basis for the genetic risk of ischemic stroke is likely to be multigenic and influenced by environmental factors. Several small case-control studies have suggested associations between ischemic stroke and polymorphisms of genes that code for coagulation cascade proteins and platelet receptors. Our aim is to investigate potential associations between hemostatic gene polymorphisms and ischemic stroke, with particular emphasis on detailed characterization of the phenotype. Methods/Design: The Ischemic Stroke Genetic Study is a prospective, multicenter genetic association study in adults with recent first-ever ischemic stroke confirmed with computed tomography or magnetic resonance imaging. Patients are evaluated at academic medical centers in the United States and compared with sex- and age-matched controls. Stroke subtypes are determined by central blinded adjudication using standardized, validated mechanistic and syndromic classification systems. The panel of genes to be tested for polymorphisms includes β-fibrinogen and platelet glycoprotein Ia, Iba, and IIb/IIIa. Immortalized cell lines are created to allow for time- and cost-efficient testing of additional candidate genes in the future. Discussion: The study is designed to minimize survival bias and to allow for exploring associations between specific polymorphisms and individual subtypes of ischemic stroke. The data set will also permit the study of genetic determinants of stroke outcome. Having cell lines will permit testing of future candidate risk factor genes.",
author = "Meschia, {James F} and Brott, {Thomas G} and Brown, {Robert D Jr.} and Crook, {Richard J P} and Michael Frankel and John Hardy and Merino, {Jos{\'e} G.} and Rich, {Stephen S.} and Scott Silliman and {Burke Worrall}, Bradford",
year = "2003",
month = "7",
day = "8",
doi = "10.1186/1471-2377-3-4",
language = "English (US)",
volume = "3",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The Ischemic Stroke Genetics Study (ISGS) Protocol

AU - Meschia, James F

AU - Brott, Thomas G

AU - Brown, Robert D Jr.

AU - Crook, Richard J P

AU - Frankel, Michael

AU - Hardy, John

AU - Merino, José G.

AU - Rich, Stephen S.

AU - Silliman, Scott

AU - Burke Worrall, Bradford

PY - 2003/7/8

Y1 - 2003/7/8

N2 - Background: The molecular basis for the genetic risk of ischemic stroke is likely to be multigenic and influenced by environmental factors. Several small case-control studies have suggested associations between ischemic stroke and polymorphisms of genes that code for coagulation cascade proteins and platelet receptors. Our aim is to investigate potential associations between hemostatic gene polymorphisms and ischemic stroke, with particular emphasis on detailed characterization of the phenotype. Methods/Design: The Ischemic Stroke Genetic Study is a prospective, multicenter genetic association study in adults with recent first-ever ischemic stroke confirmed with computed tomography or magnetic resonance imaging. Patients are evaluated at academic medical centers in the United States and compared with sex- and age-matched controls. Stroke subtypes are determined by central blinded adjudication using standardized, validated mechanistic and syndromic classification systems. The panel of genes to be tested for polymorphisms includes β-fibrinogen and platelet glycoprotein Ia, Iba, and IIb/IIIa. Immortalized cell lines are created to allow for time- and cost-efficient testing of additional candidate genes in the future. Discussion: The study is designed to minimize survival bias and to allow for exploring associations between specific polymorphisms and individual subtypes of ischemic stroke. The data set will also permit the study of genetic determinants of stroke outcome. Having cell lines will permit testing of future candidate risk factor genes.

AB - Background: The molecular basis for the genetic risk of ischemic stroke is likely to be multigenic and influenced by environmental factors. Several small case-control studies have suggested associations between ischemic stroke and polymorphisms of genes that code for coagulation cascade proteins and platelet receptors. Our aim is to investigate potential associations between hemostatic gene polymorphisms and ischemic stroke, with particular emphasis on detailed characterization of the phenotype. Methods/Design: The Ischemic Stroke Genetic Study is a prospective, multicenter genetic association study in adults with recent first-ever ischemic stroke confirmed with computed tomography or magnetic resonance imaging. Patients are evaluated at academic medical centers in the United States and compared with sex- and age-matched controls. Stroke subtypes are determined by central blinded adjudication using standardized, validated mechanistic and syndromic classification systems. The panel of genes to be tested for polymorphisms includes β-fibrinogen and platelet glycoprotein Ia, Iba, and IIb/IIIa. Immortalized cell lines are created to allow for time- and cost-efficient testing of additional candidate genes in the future. Discussion: The study is designed to minimize survival bias and to allow for exploring associations between specific polymorphisms and individual subtypes of ischemic stroke. The data set will also permit the study of genetic determinants of stroke outcome. Having cell lines will permit testing of future candidate risk factor genes.

UR - http://www.scopus.com/inward/record.url?scp=2642539412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642539412&partnerID=8YFLogxK

U2 - 10.1186/1471-2377-3-4

DO - 10.1186/1471-2377-3-4

M3 - Article

VL - 3

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

M1 - 4

ER -